Improved efficacies have led to a surge of interest in peptide drugs, classified by the U.S. FDA as biologics. As peptide drug discoveries proliferate, rather than allowing un-sustainable production methods turn the field into a victim of its own success, researchers aim to enhance peptide manufacturing. The bar set for sustainable peptide manufacturing requires it to be faster, cheaper, and more environmentally friendly than conventional methods.
Read MoreThe EPA Supports Green Chemistry, so Should Biologists
While biologists already have some choices for less toxic methods in their tool box, new discoveries in the field of green chemistry will lead to its faster adoption into life science lab work. The EPA and chemists collaborating internationally are pushing the frontiers of this trend for good reason.
Read More